Researchers from the University of Maryland and the National Institute on Drug Abuse (NIDA) have published a review article summarizing preclinical and clinical research on synthetic cannabinoids such as K2 and Spice, covering areas such as who is using the compounds and what symptoms are being reported most often in emergency room visits.
According to a Sept. 17 communication from NIDA, the article has been released at a time when jurisdictions such as the state of New Hampshire and New York City have issued alerts that warn of increasing overdoses and hospital visits related to synthetic cannabinoids, which produce unpredictable effects different from those of marijuana.
Other topics covered in the review include research findings on brain receptor binding and intensity of drug effects, as well as psychiatric effects of synthetic cannabinoids. Data on deaths associated with these compounds also are included in the article.
On Oct. 1 the Addiction Professional Panel Series will feature a discussion of trends around designer drugs and their implications for treatment professionals, to be held in the Providence, R.I., area. For more information about the panel event, click here.